文献速递皮肤肿瘤

非黑色素瘤皮肤癌与光化性角化病的患者报告健康结局:大型观察性研究分析诊断与疾病进展的影响

Patient-reported health outcomes in patients with non-melanoma skin cancer and actinic keratosis: results from a large-scale observational study analysing effects of diagnoses and disease progression.
PubMed 文献 · J Eur Acad Dermatol Venereol · 2018-01-12

该研究为德国29个皮肤科中心开展的非干预性前瞻性横断面研究,纳入1184例光化性角化病(AK)、基底细胞癌(BCC)、鳞状细胞癌(SCC)或多诊断患者,使用EQ-5D-5L问卷评估生活质量。结果显示生活质量与诊断强烈相关,单一AK诊断患者平均EQ VAS(78)显著高于BCC(74)、SCC(72)及BCC合并SCC(69),P<0.050;AK合并SCC患者平均EQ VAS(71)显著低于单一AK诊断(78),P<0.011。结论认为AK与NMSC影响生活质量,且疾病进展导致生活质量明显下降。

要点

  • 单一AK诊断患者平均EQ VAS(78)显著高于BCC(74)、SCC(72)及BCC合并SCC(69),P<0.050。
  • AK合并SCC患者平均EQ VAS(71)显著低于单一AK诊断(78),P<0.011。
  • AK与NMSC影响生活质量,疾病进展被患者感知为有害,应积极治疗以维持和恢复生活质量。

核心结论

  • AK和NMSC虽很少立即危及生命,但通过EQ-5D-5L量化显示对生活质量有影响。
  • 生活质量影响与诊断(AK vs NMSC)及临床进展(AK vs AK合并SCC)相关,两者均导致生活质量明显下降。
  • 疾病进展被患者感知和判断为有害,AK和NMSC应积极治疗以维持和恢复生活质量。

研究设计与样本

  • 非干预性、前瞻性、横断面研究,在德国29个皮肤科中心纳入AK、SCC、BCC或多诊断患者。
  • 患者完成EQ-5D-5L问卷(包括EQ指数和EQ VAS),皮肤科医生提供诊断、病史和治疗数据。
  • 共纳入1184例患者,诊断为AK者73%、BCC者49%、SCC者17%;66%为单一诊断,28%有两种不同诊断,6%有三种不同诊断。

主要发现

  • 生活质量与患者诊断强烈相关。
  • 单一AK诊断患者平均EQ VAS(78)显著高于BCC(74)、SCC(72)及BCC合并SCC(69),P<0.050。
  • AK合并SCC患者平均EQ VAS(71)显著低于单一AK诊断(78),P<0.011。

关键数值与推荐

  • 单一AK诊断平均EQ VAS为78,BCC为74,SCC为72,BCC合并SCC为69,P<0.050。
  • AK合并SCC平均EQ VAS为71,单一AK诊断为78,P<0.011。

临床怎么用

  • 临床应积极治疗AK和NMSC以维持和恢复患者生活质量。
  • 评估患者生活质量时需考虑诊断类型及疾病进展状态。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Non-melanoma skin cancer (NMSC) and actinic keratosis (AK) are very common among fair-skinned individuals. A disease continuum from AK to squamous cell carcinoma (SCC) has been frequently postulated. AK and NMSC may influence quality of life (QL) of patients, and it can be suspected that disease progression entails a QL reduction. The purpose of this study was to document QL in patients with NMSC and AK using the health-outcome questionnaire EQ-5D-5L. METHODS: The study was designed as a non-interventional, prospective, cross-sectional study. Patients with AK, SCC, basal cell carcinoma (BCC) or multiple diagnoses were enrolled in this study in 29 dermatological centres across Germany. Patients were asked to complete the EQ-5D-5L (compromising EQ Index and EQ VAS), and the dermatologists provided diagnosis, disease history and treatment data. RESULTS: A total of 1184 patients were enrolled and diagnosed as follows: 73% AK, 49% BCC and 17% SCC. 66% had a single diagnosis, 28% two different diagnoses and 6% three different diagnoses. QL was strongly associated with patients' diagnosis. Patients with a single AK diagnosis had significantly higher mean EQ VAS (78) than patients with BCC (74), SCC (72), and BCC plus SCC (69), P < 0.050. When the effects of disease progression were calculated, patients with AK plus SCC reported significantly less mean EQ VAS (71) than patients with a single AK diagnosis (78), P < 0.011. CONCLUSIONS: While rarely being imminently life-threatening, NMSC and AK have an impact on QL as quantified by the EQ-5D-5L. This impact is associated with diagnosis (AK vs. NMSC) and clinical progression (AK vs. AK plus SCC). Both lead to a clear decline in QL. This shows that disease progression is perceived and judged as detrimental by patients and that AK and NMSC should be diligently treated to preserve and restore QL.

来源:J Eur Acad Dermatol Venereol,查看原文。版权归原作者所有。

引用

  1. Philipp-Dormston WG, Müller K, Novak B, et al. Patient-reported health outcomes in patients with non-melanoma skin cancer and actinic keratosis: results from a large-scale observational study analysing effects of diagnoses and disease progression. J Eur Acad Dermatol Venereol. 2018. PMID: 29150868. doi:10.1111/jdv.14703

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。